Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Humanigen Inc
(NQ:
HGEN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 25, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Humanigen Inc
< Previous
1
2
3
4
5
6
Next >
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
September 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (...
Via
Benzinga
After FDA Rejection This Biopharma Stock Garners Analyst Downgrades, Price Cuts
September 09, 2021
JPMorgan
Via
Benzinga
Exposures
Product Safety
Mid-Afternoon Market Update: Dow Tumbles Over 100 Points; Gevo Shares Spike Higher
September 09, 2021
Toward the end of trading Thursday, the Dow traded down 0.37% to 34,901.89 while the NASDAQ fell 0.03% to 15,281.73. The S&P also rose, gaining 0.31% to 4,499.94. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Did Humanigen's Stock Dump Today And What's Next?
September 09, 2021
Humanigen Inc. (NASDAQ:HGEN) shares are trading sharply lo...
Via
Benzinga
Understanding Humanigen's Unusual Options Activity
August 10, 2021
Humanigen (NASDAQ:HGEN) shares experienced unusual option...
Via
Benzinga
48 Biggest Movers From Yesterday
September 10, 2021
Gainers Rocket Lab USA, Inc. (NASDAQ: RKLB) jumped 37.3% to settle at $20.72. Rocket Lab reported 1H sales of $29.5 million and announced it has been awarded a contract to deploy...
Via
Benzinga
Stocks Inch Higher as Dow Looks to Snap Skid
September 09, 2021
The Dow Jones Industrial Index is up 68 points midday and on track to snap a three-day losing streak.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
September 09, 2021
Gainers Impel NeuroPharma (NASDAQ:IMPL) shares increased by 22.16% to $20.29 during Thursday's regular session. Trading volume for this security as of 12:30 EST is 1.1...
Via
Benzinga
Mid-Day Market Update: Torrid Surges After Q2 Results; Humanigen Shares Slide
September 09, 2021
Midway through trading Thursday, the Dow traded up 0.10% to 35,067.66 while the NASDAQ rose 0.20% to 15,316.45. The S&P also rose, gaining 0.04% to 4,516.10. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Here's Why Humanigen Is Getting Hammered Today
September 09, 2021
An attempt to earn authorization for lenzilumab hit a wall at the FDA.
Via
The Motley Fool
Exposures
COVID-19
Product Safety
35 Stocks Moving In Thursday's Mid-Day Session
September 09, 2021
Gainers Gevo, Inc. (NASDAQ: GEVO) shares climbed 36.6% to $7.91. Chevron and Gevo announced intent to pursue sustainable aviation fuel investment. Offerpad Solutions Inc (NYSE:...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021
September 09, 2021
Upgrades According to Benchmark, the prior rating for TopBuild Corp (NYSE:
Via
Benzinga
Mid-Morning Market Update: Markets Rise; Jobless Claims Fall To 310,000
September 09, 2021
Following the market opening Thursday, the Dow traded up 0.36% to 35,158.32 while the NASDAQ rose 0.41% to 15,348.81. The S&P also rose, gaining 0.26% to 4,525.59. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Humanigen Stock Pummeled After FDA Rejects Its Experimental Covid Drug
September 09, 2021
The Food and Drug Administration rejected Humanigen's experimental Covid treatment on Thursday, sending HGEN stock into a dive.
Via
Investor's Business Daily
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 09, 2021
Gainers Soligenix (NASDAQ:SNGX) stock increased by 22.85% to $1.29 during Thursday's pre-market session. The company's market cap stands at $51.7 million. Cardiff...
Via
Benzinga
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...
Via
Benzinga
Exposures
COVID-19
21 Stocks Moving in Thursday's Pre-Market Session
September 09, 2021
Gainers Cardiff Oncology, Inc. (NASDAQ: CRDF) rose 17.3% to $8.27 in pre-market trading after the company announced new data from its Phase 1b/2 trial in KRAS-mutated metastatic...
Via
Benzinga
See Why Humanigen Stock Is Plunging To 52-Week Low
September 09, 2021
The FDA declined Humanigen Inc's (NASDAQ: HGEN) request for emergency use authorization (EUA) of its lenzilumab drug to treat newly hospitalized COVID-19...
Via
Benzinga
Exposures
Product Safety
Analyzing Humanigen's Unusual Options Activity
August 16, 2021
Humanigen (NASDAQ:HGEN) shares experienced unusual options activity on Monday. The stock price moved down to $16.48 following the option alert. Sentiment: BULLISH Option Type:...
Via
Benzinga
I-Mab Stock Is Trading Lower After Unveiling Mid-Stage Trial Data Of Plonmarlimab In Hospitalized COVID-19 Patients
August 11, 2021
I-Mab (NASDAQ: IMAB) has announced interim data from its Phase 2/3 study evaluating plonmarlimab (TJM2 or TJ003234) for cytokine release syndrome (CRS) in patients...
Via
Benzinga
Exposures
COVID-19
Humanigen's COVID-19 Candidate Shows 2.5 Fold Increase In Survival Without Ventilation
August 04, 2021
Humanigen Inc (NASDAQ: HGEN) has announced an analysis of results from its Phase 3 LIVE-AIR study of lenzilumab in hospitalized patients with COVID-19. Data...
Via
Benzinga
Exposures
COVID-19
Unusual Options Activity Insight: Humanigen
July 19, 2021
Shares of Humanigen (NASDAQ:HGEN) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved up to $16.85. Sentiment: BEARISH Option...
Via
Benzinga
Humanigen Stock Jumps As Lenzilumab Application Is Under Review In UK For COVID-19
July 09, 2021
The U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA) has accepted for review Humanigen Inc's (NASDAQ: HGEN) marketing application seeking...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 09, 2021
Gainers Galectin Therapeutics (NASDAQ:GALT) shares moved upwards by 47.46% to $4.07 during Friday's pre-market session. The market value of their outstanding shares is...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 11, 2021
June 11, 2021
Upgrades Barclays upgraded the previous rating for Ventas Inc (NYSE:VTR) from Equal-Weight to Overweight. In the first quarter, Ventas showed an EPS of $0.72, compared to...
Via
Benzinga
The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO
July 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc...
Via
Benzinga
Why This COVID-19 Stock Is On Fire Right Now
June 11, 2021
While vaccines and diagnostics have been the big winners in the space so far, Humanigen might make investors a lot of money with its drug to treat cytokine storms caused by COVID-19.
Via
The Motley Fool
Exposures
COVID-19
Moderna Taps Thermo Fisher to Help Scale Up COVID-19 Vaccine Production
June 02, 2021
Moderna Inc (NASDAQ: MRNA) entered into an agreement with Thermo Fisher Scientific Inc (NYSE: TMO) for manufacturing and packaging its COVID-19 vaccine,...
Via
Benzinga
Exposures
COVID-19
68 Biggest Movers From Yesterday
June 02, 2021
Gainers Orbital Energy Group, Inc. (NASDAQ: OEG) shares surged 115.2% to close at $7.64 on Tuesday after the company announced its subsidiary, Gibson Technical Services, reached...
Via
Benzinga
36 Stocks Moving In Tuesday's Mid-Day Session
June 01, 2021
Gainers Orbital Energy Group, Inc. (NASDAQ: OEG) shares jumped 67.3% to $5.94 after the company announced its subsidiary, Gibson Technical Services, reached an agreement with TEC...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.